Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT06027567
What this trial is testing

The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure

Who this might be right for
Idiopathic Intracranial HypertensionIntracranial PressureObesity+3 more
Rigmor Højland Jensen 38
Not applicableEnrolling By InvitationNCT01511393
What this trial is testing

An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Medullary Thyroid Carcinoma+1 more
Novo Nordisk A/S 6,750
Not applicableStudy completedNCT02879955
What this trial is testing

Carbohydrates and Gut Hormones After Gastric Bypass Surgery

Who this might be right for
Overweight
Hvidovre University Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT05960565
What this trial is testing

Glucagon Enhanced Insulin Absorption in Diabetes Mellitus Type 1

Who this might be right for
Type 1 Diabetes
St. Olavs Hospital 9
Not applicableStudy completedNCT04926415
What this trial is testing

Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Obesity and Insulin Resistance

Who this might be right for
Diabetes Mellitus, Type 2Obesity
Burrell College of Health Sciences 30
Not applicableStudy completedNCT02385617
What this trial is testing

Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer

Who this might be right for
Esophageal NeoplasmsStomach NeoplasmsWeight Loss+1 more
St. James's Hospital, Ireland 20
Testing effectiveness (Phase 2)Study completedNCT01930097
What this trial is testing

Closed-loop Control of Glucose Levels After Meal Intake in Adults With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Institut de Recherches Cliniques de Montreal 12
Not applicableUnknownNCT02887625
What this trial is testing

Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

Who this might be right for
Type 2 Diabetes
Dr. Muhammad Abdulghani 410
Not applicableUnknownNCT02490176
What this trial is testing

Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters

Who this might be right for
Heart Failure
Chinese PLA General Hospital 50
Post-approval studies (Phase 4)UnknownNCT00155376
What this trial is testing

Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography

Who this might be right for
Liver Disease
National Taiwan University Hospital 100
Post-approval studies (Phase 4)Not Yet RecruitingNCT07547878
What this trial is testing

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Baylor Research Institute 64
Large-scale testing (Phase 3)Study completedNCT01733758
What this trial is testing

A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 494
Not applicableStudy completedNCT01740921
What this trial is testing

GLP-1 and Microvascular Function in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Royal Devon and Exeter NHS Foundation Trust 39
Not applicableStudy completedNCT06500143
What this trial is testing

Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery

Who this might be right for
Gastric Retention
Ciusss de L'Est de l'Île de Montréal 94
Not applicableLooking for participantsNCT06770621
What this trial is testing

Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes

Who this might be right for
Severe HypoglycemiaType1diabetes
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 1,000
Not applicableStudy completedNCT00834938
What this trial is testing

Comparison Between Patients With or Without Diabetes Recovery After Bariatric Surgery

Who this might be right for
DiabetesBariatric SurgeryObesity
University of Campinas, Brazil 24
Large-scale testing (Phase 3)Looking for participantsNCT07284875
What this trial is testing

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Who this might be right for
ObesityOverweight
Kailera 2,340
Large-scale testing (Phase 3)Looking for participantsNCT07083154
What this trial is testing

Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)

Who this might be right for
Dementia, MildMild Cognitive ImpairmentType 2 Diabetes
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 420
Early research (Phase 1)Study completedNCT00393445
What this trial is testing

Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans

Who this might be right for
Hyperglycemia
Ludwig-Maximilians - University of Munich 6
Not applicableStudy completedNCT02036710
What this trial is testing

Location of GLP-1 Release

Who this might be right for
Obesity
University of Minnesota 12
Next Page